Genomic epidemiology of carbapenemase-producing Enterobacteriaceae in hospitalised patients in Bangkok, Thailand from 2015 to 2017.

Few antimicrobial treatment options are available at this time for treatment of CPE infections, and only a few studies have thus far described the epidemiology of CPE in hospitalised patients. B Methods and materials: b The clinical characteristics of 33 hospitalised patients with CPE, including patient history and factors associated with the development of CPE infections, were examined. B Background: b Infections due to carbapenemase-producing Enterobacteriaceae (CPE) have continually grown as a global public health threat, with significant related mortality rates observed. [Extracted from the article]